Full bibliography
A Multicenter Study of Irrigation and Debridement in Total Knee Arthroplasty Periprosthetic Joint Infection: Treatment Failure Is High
- Urish, Kenneth L. (Author)
- Bullock, Andrew G. (Author)
- Kreger, Alexander M. (Author)
- Shah, Neel B. (Author)
- Jeong, Kwonho (Author)
- Rothenberger, Scott D. (Author)
- Irrgang, James J. (Author)
- Klatt, Brian A. (Author)
- Hamlin, Brian R. (Author)
Summary:
Key Question: What is the failure rate, timing of failure, and factors predicting failure for irrigation and debridement with component retention in treating periprosthetic joint infection of total knee arthroplasty?
Key Findings:
- The overall failure rate was 57.4% at 4 years.
- The median time to failure was 14 months.
- 89.9% of failures occurred within the first year.
- Duration of symptoms >1 week and Staphylococcus aureus infection were independent predictors of failure.
Clinical Implications:
- Irrigation and debridement with component retention has a high failure rate in treating TKA periprosthetic joint infection.
- It should be used selectively in optimal conditions (symptoms <1 week, non-S. aureus organism).
Strengths:
- Multicenter study with large sample size (n=216)
- Extended follow-up time (median 31.5 months)
- Used validated measures (e.g. Charlson Comorbidity Index)
- Performed multivariable analysis to identify predictors of failure
Limitations:
- Retrospective observational design
- Heterogeneous surgical treatment and postoperative care
- Did not assess antibiotic therapy duration/type
- Definition of failure based solely on need for additional procedures
Level of Evidence:
GRADE assessment: Moderate
Rationale: This was a well-designed multicenter observational cohort study. However, the retrospective design and lack of controlling for confounding factors reduces the level of evidence. The study did have several strengths including a large sample size, extended follow-up time, and use of validated measures. However it’s limitations like the heterogeneity in treatment and lack of assessing antibiotic therapy prevent a rating of high quality evidence.